Unknown risks of psychosis and addiction with delta‐8‐THC: A call for research, regulation, and clinical caution-Reference-Cited by-同舟云学术

Unknown risks of psychosis and addiction with delta‐8‐THC: A call for research, regulation, and clinical caution

Published:2022-03-24 Issue:9 Volume:117 Page:2371-2373
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Dotson Samuel¹,Johnson‐Arbor Kelly²,Schuster Randi M.³,Tervo‐Clemmens Brenden³,Evins A. Eden³

Affiliation:

1. Atrium Health Department of Psychiatry Charlotte NC USA

2. MedStar Georgetown University Hospital and the National Capital Poison Center Washington DC USA

3. Massachusetts General Hospital Department of Psychiatry and Harvard Medical School Boston MA USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.15873

Reference19 articles.

1. Regulatory approaches to cannabidiol in the European Union: are market developments sowing the seeds of confusion?

2. Public interest in ∆8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆9-Tetrahydrocannabinol (delta-9-THC) use

3. Consumer experiences with delta‐8‐THC: Medical use, pharmaceutical substitution, and comparisons with delta‐9‐THC;Kruger D;Cannabis Cannabinoid Res,2021

4. Delta-8-THC: Delta-9-THC’s nicer younger sibling?

5. Δ8‐THC: Legal status, widespread availability, and safety concerns;Babalonis S;Cannabis Cannabinoid Res,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case Series;Journal of Clinical Psychopharmacology;2024-07-16

2. The Development of Cannabinoids as Therapeutic Agents in the United States;Pharmacological Reviews;2024-06-07

3. Delta-8-tetrahydrocannabinol Associated Manic Switch: A Case Report;Indian Journal of Psychological Medicine;2024-01-20

4. Associations between cannabis risk perceptions and Delta-8 THC use among young adults;Journal of Substance Use;2023-12-14

5. Now I know my CBDs; cases of psychiatric admissions after delta-8-tetrahydrocannabinol (delta-8-THC, Δ⁸-THC) product usage;Psychiatry Research Case Reports;2023-12